Why the study?
Does the ultrasound-based sarcoma screening (USS) score improve diagnostic efficacy for differentiating malignant from benign soft-part tumours compared to Doppler ultrasound alone in patients with soft-part tumours?
Does the ultrasound-based sarcoma screening (USS) score improve diagnostic efficacy for differentiating malignant from benign soft-part tumours compared to Doppler ultrasound alone in patients with soft-part tumours?
The ultrasound-based sarcoma screening (USS) score, combining Doppler vascularity with tumor size and ultrasound morphology, significantly improves the sensitivity of differentiating malignant from benign soft tissue tumors compared to Doppler vascularity alone.
May enhance sarcoma detection sensitivity over Doppler alone; extends prior data but leaves open prospective validation.
BACKGROUND: The utility of ultrasound imaging in the screening of soft-part tumours (SPTs) has been reported. We classified SPTs according to their blood flow pattern on Doppler ultrasound and re-evaluated the efficacy of this imaging modality as a screening method. Additionally, we combined Doppler ultrasound with several values to improve the diagnostic efficacy and to establish a new diagnostic tool. PATIENTS AND METHODS: This study included 189 cases of pathologically confirmed SPTs (122 cases of benign disease including SPTs and tumour-like lesions and 67 cases of malignant SPTs). Ultrasound imaging included evaluation of vascularity by colour Doppler. We established a scoring system to more effectively differentiate malignant from benign SPTs (ultrasound-based sarcoma screening [USS] score). RESULTS: The mean scores in the benign and malignant groups were 1.47 ± 0.93 and 3.42 ± 1.30, respectively. Patients with malignant masses showed significantly higher USS scores than did those with benign masses (p < 1 × 10(-10)). The area under the curve was 0.88 by receiver operating characteristic (ROC) analysis. Based on the cut-off value (3 points) calculated by ROC curve analysis, the sensitivity and specificity for a diagnosis of malignant SPT was 85.1% and 86.9%, respectively. CONCLUSIONS: Assessment of vascularity by Doppler ultrasound alone is insufficient for differentiation between benign and malignant SPTs. Preoperative diagnosis of most SPTs is possible by combining our USS score with characteristic clinical and magnetic resonance imaging findings.
No takes yet. Share an insight, caveat, or question.
Nagano et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: